Prices delayed by at least 15 minutes | Print
Legal & General Ucits Etf Public Limited Company L&G PHARMA BREAKTHROUGH GO UCITS ETF
Asset allocation %
Morningstar style box TM
Equity style
SizeLarge
Mid
Small
Value
Blend
Growth
Style
Size
| Share class size (mil) | 18 GBP (19/11/2026) |
| Fund size (mil) | 18 GBP (19/11/2026) |
Top 10 holdings
| Assets in top 10 holdings % | 33.02 |
| Total number of equity holdings | 40 |
| Total number of bond holdings | 0 |
| Holdings 18/11/2026 | % of assets |
|---|---|
| Xeris Biopharma Holdings Inc | 5.22 |
| Genmab AS | 3.99 |
| Xencor Inc | 3.39 |
| United Therapeutics Corp | 3.10 |
| Biogen Inc | 2.98 |
| BeOne Medicines Ltd ADR | 2.95 |
| AstraZeneca PLC | 2.90 |
| Eisai Co Ltd | 2.87 |
| Royalty Pharma PLC Class A | 2.81 |
| Basilea Pharmaceutica Ltd Registered Shares | 2.81 |